FDA considers removing some warnings for hormone treatment of menopause

MONROE, La. (KNOE) - New research shows that hormone therapy for women experiencing menopause might come with a smaller risk than originally thought.

Hormone therapy uses estrogen, and sometimes progestin, to treat menopause. The FDA has long mandated “black box” labels on the medication to warn about risks of stroke, blood clots, dementia and breast cancer.

Many women have been wary of the treatment because of these black box labels, but the FDA is now considering removing some of those warnings.

Dr. Mary Rosser said it’s a step in the right direction.

Rosser treats 53-year-old Isabel Kallman, whose life has been disrupted by hot flashes and sleepless nights.

Kallman’s symptoms are part of perimenopause, the phase before menopause when a woman’s hormones start to decline.

Rosser sai